Iterative Scopes Company
Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space.
Investors
Founded Date:
2017
Total Funding:
19049241
Investor Type:
For Profit
Employee Number:
101-250
Funding Status:
Early Stage Venture
Technology:
['BioTech & HealthTech']
Last Funding Type:
Series A
Investors Number:
5
Industry:
HealthCare Administration
Headquarters:
Cambridge, Massachusetts, United States
Estimated Revenue:
Less than $1M